Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MCRPC (metastatic Castration-resistant Prostate Cancer)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06136624
What this trial is testing

Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

Who this might be right for
Prostate Cancer Metastatic
Merck Sharp & Dohme LLC 1,310
Testing effectiveness (Phase 2)Ended earlyNCT03545165
What this trial is testing

177Lu-J591 and 177Lu-PSMA-617 Combination for mCRPC

Who this might be right for
Prostate Cancer
Weill Medical College of Cornell University 6
Testing effectiveness (Phase 2)Ended earlyNCT03741712
What this trial is testing

SHR2554 Alone or in Combination With SHR3680 in the Treatment of mCRPC

Who this might be right for
Prostate CancerCastration-resistant Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd. 9
Testing effectiveness (Phase 2)Study completedNCT03658447
What this trial is testing

PRINCE (PSMA-lutetium Radionuclide Therapy and ImmuNotherapy in Prostate CancEr)

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Peter MacCallum Cancer Centre, Australia 37
Not applicableStudy completedNCT02426333
What this trial is testing

Optimizing Abiraterone Therapy

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Radboud University Medical Center 56
Testing effectiveness (Phase 2)Study completedNCT02020135
What this trial is testing

An Open-label Extension Study of PSMA ADC 2301 in mCRPC

Who this might be right for
Prostate Cancer
Progenics Pharmaceuticals, Inc. 9
Early research (Phase 1)Study completedNCT03030885
What this trial is testing

Use of an Experimental Radiopharmaceutical (131I-MIP-1095) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostate CancerMetastatic Castration-Resistant Prostate Cancer (mCRPC)
Memorial Sloan Kettering Cancer Center 10
Testing effectiveness (Phase 2)Study completedNCT02445976
What this trial is testing

Once-daily Oral Seviteronel in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone.

Who this might be right for
Prostate Cancer
Innocrin Pharmaceutical 197
Not applicableAvailableNCT05650476
What this trial is testing

Pre-approval Single-patient Expanded Access for Talazoparib (PF-06944076)

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Pfizer
Testing effectiveness (Phase 2)Temporarily pausedNCT04071236
What this trial is testing

Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy

Who this might be right for
Metastatic Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Malignant Neoplasm in the Lymph Nodes+1 more
National Cancer Institute (NCI) 90
Early research (Phase 1)Ended earlyNCT04575766
What this trial is testing

FT-7051 in Men With MCRPC

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Novo Nordisk A/S 25
Testing effectiveness (Phase 2)Study completedNCT04089553
What this trial is testing

An Open-label, Phase II Study of AZD4635 in Patients With Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Castration-Resistant Prostate Cancer (mCRPC)
AstraZeneca 59
Testing effectiveness (Phase 2)Looking for participantsNCT06863272
What this trial is testing

A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

Who this might be right for
Castration-Resistant Prostatic CancerMetastasis
Merck Sharp & Dohme LLC 360
Testing effectiveness (Phase 2)Looking for participantsNCT06190899
What this trial is testing

Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
mCRPC (Metastatic Castration-resistant Prostate Cancer)Genital Diseases, MaleUrogenital Diseases, Male+3 more
Celcuity Inc 54
Very early researchActive Not RecruitingNCT06866548
What this trial is testing

Safety and Efficacy Evaluation of Anti IGF-1R Monoclonal Antibody Combined With Anti-PD-1 Monoclonal Antibody in Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
mCRPC
Shanghai Changzheng Hospital 7
Not applicableStudy completedNCT06809426
What this trial is testing

Evaluating the Safety and Efficacy of 177Lu-LNC1011 Injection in a Single-Center, Single-Arm, Open Study in Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Desmoplasia-Resistant Prostate Cancer

Who this might be right for
PSMA PET-Positive Castration-Resistant Prostate Cancer
Affiliated Hospital of Jiangnan University 13
Early research (Phase 1)Looking for participantsNCT05942001
What this trial is testing

Study of HRS-5041 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Who this might be right for
Advanced Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd. 100
Early research (Phase 1)Not Yet RecruitingNCT07803653
What this trial is testing

IL-18 Armored STEAP1 CAR T Cells for the Treatment of Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8
Fred Hutchinson Cancer Center 20
Early research (Phase 1)Study completedNCT03822871
What this trial is testing

A Trial of CTT1403 for Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Cancer Targeted Technology 17
Not applicableEnded earlyNCT05301062
What this trial is testing

A Research Called CREDIT Studies How Safe the Study Treatment Radium-223 is and How Well it Works in Chinese Men With Advanced Prostate Cancer That Has Spread to the Bones and Does Not Respond to Treatments for Lowering Testosterone Levels

Who this might be right for
Metastatic Castration-resistant Prostate CancerBone Metastases
Bayer 8
Next Page